Facebook
Twitter
LinkedIn
Forward
2019 Comprehensive Review of Pain Management
Statement of Need
The University of Wisconsin School of Medicine and Public Health faculty in Pain Medicine, Family Medicine and Community Health, Anesthesiology, Neurology, Orthopedics and Rehabilitation, and the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) are pleased to offer the 17th Comprehensive Review of Pain Management at the Fluno Center in Madison, Wisconsin, on August 5-9, 2019.
The current national opioid epidemic has highlighted gaps in prevention, assessment and treatment of pain and opioid-related harms at all levels. Under-treatment as well as inappropriate pain management have contributed to suboptimal treatment outcomes, opioid misuse and use disorders, overdose, patient and provider dissatisfaction, and escalating national costs. This activity addresses knowledge and existing practice gaps in education and training in pain medicine.
Highlights:
- Review of best clinical practices in pain management by expert multidisciplinary faculty
- Education on judicious and balanced opioid use, risk assessment, mitigation, monitoring, strategies for opioid taper, and opioid-sparing treatment approaches
- Overview of current evidence on applications of cannabinoids to pain care
- Education about issues overlapping pain and opioid use disorders (OUDs), the diagnosis and treatment of OUD, and pain management approaches in individuals with OUD
- Up-to-date, intensive review of Pain Medicine and related disorders for board certification/recertification
- Focus on topics of interest to Primary Care and other interdisciplinary clinicians on Wednesday, August 7 - Friday, August 9
- 37.5 hours of instruction
Intended Audience
This activity has been planned by and for an interprofessional audience of clinicians, including pain medicine, addiction medicine, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists interested in obtaining an overview of pain management.
Elements of Competence
This CE activity has been designed to the interprofessional (IP) areas of values/ethics for IP practice, roles/responsibilities, interprofessional communication and teams/teamwork.
Learning Objectives
At the conclusion of this educational activity, participants will be able to:
- Review neuroanatomy and neurophysiology of pain pathways.
- Describe pathophysiology of acute and chronic pain.
- Learn to communicate with patients effectively
- Describe comorbid psychiatric conditions, discuss psychological evaluation and summarize evidence for common behavioral treatments such as mindfulness meditation, cognitive behavioral therapy, relaxation, biofeedback, hypnosis.
- Describe pain management approaches in children, elderly, pregnant and lactating women, and those with cancer.
- Describe the assessment and management of headache, complex regional pain syndrome (CRPS), neuropathic pain, myofascial pain, fibromyalgia, and pelvic pain.
- Recognize, interpret and clinically correlate radiological abnormalities in common musculoskeletal pain disorders of the spine and peripheral joints.
- Outline a multimodal treatment plan for common pain conditions incorporating pharmacological, rehabilitation, behavioral/psychological, complementary and alternative medicine, interventional, and surgical treatments.
- Describe analgesic pharmacology and clinical applications of opioid and non-opioid analgesics and other pharmacotherapies for acute and chronic pain.
- Review the anatomy, indications, and contraindications for regional anesthetic blocks, different types of peripheral and spinal nerve blocks, and other advanced pain treatments for headache and facial pain, spinal pain, CRPS, osteoarthritic musculoskeletal and neuropathic pain conditions.
- Describe role of spinal cord stimulators and pumps in pain management.
- Summarize the evidence for regenerative medicine treatments for musculoskeletal pain conditions.
- Discuss integrative medicine approaches to treating pain.
- Discuss opioid therapy and related issues in pain management
- State approaches aimed at improving safety and efficacy of pain management with opioids: how to initiate, maintain, monitor compliance, taper and discontinue opioids.
- Discuss pain management in patients on long-term,high-dose opioid therapy.
- Describe adverse effects of long-term opioid therapy.
- Discuss the problems of prescription opioid misuse/abuse in chronic pain.
- Explain the role of urine drug testing and discuss the interpretation of results.
- Summarize diagnosis and treatment of opioid use disorder, and discuss approaches to reduce addiction-related harm.
- Describe strategies to manage pain without opioids, including IV lidocaine and ketamine infusions, nerve blocks, neuromodulation, integrative medicine and non-pharmacologic approaches.
- Describe policies and DEA regulations pertaining to prescribing controlled substances, and appropriate record keeping.
Additional Information
| Attachment | Size |
|---|---|
 Comprehensive Review of Pain Management brochure | 1.42 MB |
| Monday, August 5 | |
| 7:00 | Registration and Breakfast |
| 7:30 | Welcome |
| 7:45 | Acute Pain Management: Neurobiology of Pain - Applying Basic Science Knowledge to Daily Practice Oscar A. de Leon-Casasola, MD |
| 8:15 | Managing Pain Postoperatively: Alternatives for Postoperative Pain Oscar A. de Leon-Casasola, MD |
| 8:45 | Pain Syndromes in Cancer Oscar A. de Leon-Casasola, MD |
| 9:15 | Q&A |
| 9:45 | Management of Acute and Chronic Pain in Cancer and Palliative Care Oscar A. de Leon-Casasola, MD |
| 10:30 | Receptor, Ion Channels and Channelopathies in Pain Thomas S. McDowell, MD, PhD |
| 11:00 | Q&A |
| 11:15 | Anatomy and Physiology of Pain Pathways Tony L. Yaksh, PhD |
| 11:45 | Mechanism of Pain States Tony L. Yaksh, PhD |
| 12:30 | Lunch |
| 1:30 | Assessment and Diagnosis of Neuropathic Pain Misha Backonja, MD |
| 2:00 | Neuropathic Pain: Therapeutic Considerations Misha Backonja, MD |
| 2:30 | Pharmacotherapy of Neuropathic Pain June L. Dahl, PhD |
| 3:00 | Q&A |
| 3:15 | Break |
| 3:30 | Implantable Pumps in Pain Management Timothy R. Deer, MD, DABPM, FIPP |
| 4:15 | Spinal Cord Stimulation in Chronic Pain: Current Status Timothy R. Deer, MD, DABPM, FIPP |
| 5:00 | Q&A |
| 5:15 | Adjourn |
| Tuesday, August 6 | |
| 7:00 | Breakfast |
| 7:45 | Musculoskeletal Pain: Clinical and Radiologic Correlation Donna Blankenbaker, MD & James Leonard, DO |
| 8:45 | Chronic Spinal Pain: Clinical and Radiologic Correlation Donna Blankenbaker, MD & James Leonard, DO |
| 9:45 | Chronic Spinal Pain: Spinal Injections Nalini Sehgal, MD |
| 10:30 | Break |
| 10:45 | Chronic Spinal Pain: Surgical Treatments Miranda J. Bice, MD |
| 11:30 | CRPS and Sympathetic Blocks Nalini Sehgal, MD |
| 12:15 | Q&A |
| 12:30 | Lunch |
| 1:30 | Headache: Clinical Assessment Shawna Wheeler, PA-C |
| 1:45 | Headache: Trigemino-cervical Complex Elizabeth Lake, MD |
| 2:00 | Primary Headache Disorder: Approach to Diagnosis and Treatment Susanne Seeger, MD |
| 2:45 | Secondary Headache Disorders Elizabeth Lake, MD |
| 3:15 | Q&A |
| 3:30 | Break |
| 3:45 | Headache and Atypical Facial Pain: Cranial Nerve Blocks and Radiofrequency Ablation Alaa Abd-Elsayed, MD |
| 4:30 | Approach to Female Patient with Chronic Pelvic Pain Cara King, DO, MS & Sarah McAchran, MD |
| 5:30 | Q&A |
| 5:45 | Adjourn |
| Wednesday, August 7 | |
| 7:00 | Breakfast |
| 7:45 | Psychiatric Comorbidity in Chronic Pain Michael Clark, MD, MPH, MBA |
| 8:45 | Treatment of Depression, Anxiety and Sleep Problems Michael Clark, MD, MPH, MBA |
| 9:45 | Break |
| 10:00 | Psychological Evaluations in Chronic Pain Shilagh A. Mirgain, PhD |
| 10:45 | Complex Psychiatric Comorbidity in the Context of Pain Management Rob Edwards, PhD, MSPH |
| 11:30 | Psychological Interventions in Chronic Pain Shilagh A. Mirgain, PhD |
| 12:15 | Q&A |
| 12:30 | Lunch |
| 1:30 | Pain in Children: Assessment Peggy Riley, MN, MPH, RN |
| 2:00 | Chronic Pain in Children: Management Timothy W. Casias, MD |
| 2:30 | Pain in the Elderly: Assessment and Management Nathan J. Rudin, MD, MA |
| 3:15 | Break |
| 3:30 | Myofascial Pain Syndrome Nathan J. Rudin, MD, MA |
| 4:15 | Acetaminophen, Antiinflammatory, and Antispasmodics Medications in Pain Care Christi Albert, PharmD BCPS |
| 5:00 | Fibromyalgia and Other Central Sensitization Pain Syndromes Nathan J. Rudin, MD, MA |
| 5:45 | Adjourn |
| Thursday, August 8 | All Thursday lectures may meet opioid related CME required by the State of Wisconsin Schedule UPDATE - Michael McNett will now be presenting at 1:30 and Michael Larson |
| 7:00 | Breakfast |
| 8:00 | Opioid Analgesics: Mechanisms of Action, Pharmacology and Adverse Effects Paul Hutson, PharmD, BCOP |
| 8:45 | Efforts at Curbing Opioid Harms: Learning from a Decade of Interventions at Marshfield Clinic Health System in Wisconsin Michael Larson, PhD |
| 9:30 | Legacy Patients - Ethical, Safe, and Compassionate Management of Those Highly Tolerant to Opioids Edward C. Covington, MD |
| 10:15 | Q&A |
| 10:30 | Break |
| 10:45 | Opioid Use Disorder: Diagnosis and Treatment Rhitu Bhatnagar, MD, MPH |
| 11:30 | Interpretation of Urine Drug Testing: Abnormal Results - What Now? John Ewing, MD |
| 12:15 | Q&A |
| 12:30 | Lunch |
| 1:30 | Opioid Therapy for Chronic Pain: Is There a Role? Why, When, and How Michael McNett, MD |
| 2:15 | Opioid Sparing Strategies: A Role for Lidocaine and Ketamine Infusions? Nalini Sehgal, MD & Steven J. Garlow, MD, PhD |
| 3:00 | Q&A |
| 3:15 | Break |
| 3:30 | Pain Management in Patients with Opioid Use Disorder David Galbis-Reig, MD, DFASAM |
| 4:30 | Cannabinoids and Pain Management David Galbis-Reig, MD, DFASAM |
| 5:30 | Adjourn |
| Friday, August 9 | |
| 7:00 | Breakfast |
| 7:45 | Regenerative Medicine Treatments for Chronic Musculoskeletal Pain Annette M. Zaharoff, MD |
| 8:30 | Integrative Therapies for Chronic Pain: Evidence and Application Adam Rindfleisch, MD |
| 9:15 | Q&A |
| 9:30 | Regional Anesthetic Blocks for Acute and Chronic Pain Thomas J. Faull, DO, DC |
| 10:15 | Q&A |
| 10:30 | Break |
| 10:45 | Assessment and Management of Pain in Pregnant Women Sreevalli Atluru, MD & Jacquelyn Adams, MD |
| 11:15 | Management of Pain in Breastfeeding Women Sreevalli Atluru, MD & Jacquelyn Adams, MD |
| 11:45 | DEA Regulations and Lawful Prescribing of Controlled Substances: Focus on Opioids Aaron Gilson, MS, MSSW, PhD |
| 12:30 | Adjourn & Box Lunch |
Conference Housing
A block of rooms has been reserved at the Fluno Center. Please call the hotel directly to reserve your accommodation. The room rate is $159. The block of rooms will be held on a first-come, first served basis and any available rooms that have not been reserved by Friday, July 5, 2019, will be released.
Madison, Wisconsin has one major airport (MSN), the Dane County Regional Airport. The Fluno Center is approximately 20 minutes from the airport.
Conference Attire
Casual attire is appropriate for this conference. Since meeting room temperatures and personal comfort levels vary, it is recommended that you bring a sweater or jacket to the educational activity.
Travel
from Minneapolis or La Crosse (via I-90/94)
Exit I-94 at Hwy 151 (south) toward the State Capitol. Follow Hwy 151 (E. Washington Ave.) about 5 miles. One block before the Capitol, turn right onto Webster St. Follow this street about 3 blocks as it curves (and changes names). Turn right onto Wisconsin Ave. Go 2 blocks and turn left onto Gorham St. This one-way street turns into University Ave. at the UW campus. Turn left onto Frances St. The Fluno Center entry is on the right side of the street, and parking is located under the building.
from Milwaukee (via I-94)
Where I-94 intersects with I-90, follow the signs for Hwy 30 into Stoughton Rd. Madison. Exit at Hwy 151 (E. Washington Ave.) toward the State Capitol. Follow E. Washington Ave. about 3 miles. One block before the Capitol, turn right onto Webster St. Follow this street about 3 blocks as it curves (and changes names). Turn right onto Wisconsin Ave. Go 2 blocks and turn left onto Gorham St. This one-way street turns into University Ave. at the UW campus. Turn left onto Frances St. The Fluno Center entry is on the right side of the street, and parking is located under the building.
from Chicago (via I-90)
Take I-90 to Madison. Exit Hwy 12&18 west. Follow Hwy 12&18 (the Beltline Hwy) for about 6 miles. Exit at Park St. (Hwy 151 north). Turn right onto Park St. and go north about 2 miles to the UW campus. Turn right onto W. Johnson St. and go for 2 blocks. Turn left onto Frances St. The Fluno Center entry is on the left side of the street, and parking is located under the building.
from Dubuque (via Hwy 151)
Take Hwy 151 north to Madison. Go under the Beltline (Hwys 12/14/18/151) and angle left onto Midvale Blvd. Follow Midvale Blvd. about 3 miles where it ends at University Ave. Turn right and take University Ave. as it becomes Campus Drive and then Johnson St. at the UW campus. Turn right onto W. Johnson St. and go for 2 blocks. Turn left onto Frances St. The Fluno Center entry is on the left side of the street, and parking is located under the building.
from Green Bay/Fox Valley (via Hwy 151)
Take Hwy 151 south (which becomes E. Washington Ave.) toward the State Capitol. One block before the Capitol, turn right onto Webster St. Follow this street about 3 blocks as it curves (and changes names). Turn right onto Wisconsin Ave. Go 2 blocks and turn left onto Gorham St. This one-way street turns into University Ave. at the UW campus. Turn left onto Frances St. The Fluno Center entry is on the right side of the street, and parking is located under the building.
COURSE DIRECTOR
Nalini Sehgal, MD
COURSE CO-DIRECTOR
Aleksandra Zgierska, MD, PhD
VISITING FACULTY
Michael R. Clark, MD, MPH, MBA; Chair, Department of Psychiatry, Inova Fairfax Hospital, Falls Church, VA
Edward C. Covington, MD; Emeritus Staff, Cleveland Clinic Foundation; Former Director, Neurological Center for Pain; Shaker Heights, OH
Timothy R. Deer, MD, DABPM, FIPP; President and CEO, The Spine and Nerve Center of The Virginias, Charleston, WV
Oscar A. de Leon-Casasola, MD; Professor of Anesthesiology and Medicine; Senior Vice-Chair, Department of Anesthesiology, University at Buffalo, School of Medicine; Chief, Division of Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY
Rob Edwards, PhD, MSPH; Associate Professor, Department of Anesthesiology, Brigham and Women’s Hospital, Boston, MA
John R. Ewing, MD; Medical Co-Director of Addiction Medicine, UnityPoint Health–Meriter, NewStart Addiction and Substance Abuse Program, Madison, WI
Thomas Faull, DO, DC; Division Chief, Pain Management SSM Health, Dean Medical Group, Madison, WI
David Galbis-Reig, MD, DFASAM; Medical Director of Addiction Medicine, Ascension Wisconsin All Saints; President-Elect, Wisconsin Society of Addiction Medicine; VP-MD, Wisconsin Medical Society Foundation; Racine, WI
Cara R. King, DO, MS; Division Director of Benign Gynecologic Surgery, Associate Program Director of Minimally Invasive Gynecologic Surgery Fellowship, Cleveland Clinic, Cleveland, OH
Michael Larson, PhD; Health / Pain Psychologist, Marshfield Clinic Health System; Director of Controlled Medication Policy, Marshfield Clinic Health System, Minocqua, WI
Michael McNett, MD; Aurora Pain Management Leader: Medical, Aurora Health System, Milwaukee, WI
Tony L. Yaksh, PhD; Professor, Department of Anesthesiology and Professor of Pharmacology, University of California, San Diego, La Jolla, CA
Annette M. Zaharoff, MD; Medical Director, Non-Surgical Center of Texas, San Antonio, TX
UNIVERSITY OF WISCONSIN–MADISON FACULTY
*=Planning Committee member
Alaa Abd-Elsayed, MD;* Assistant Professor, Department of Anesthesiology; Medical Director, UW Health Pain Services; Medical Director, UW Pain Clinic
Jacquelyn Adams, MD; Assistant Professor, Department of Obstetrics and Gynecology
Christi Ann Albert, PharmD BCPS; Clinical Pharmacy, UW Health, University Hospital
Sreevalli Atluru, MD; Assistant Professor, Department of Family Medicine and Community Health
Miroslav "Misha" Backonja, MD;* Emeritus Professor of Neurology, University of Wisconsin; Senior Medical Director, Worldwide Clinical Trials, Seattle WA
Terese M. Bailey;* Senior Outreach Specialist, Office of Continuing Professional Development in Medicine and Public Health, University of Wisconsin–Madison ICEP
Ritu Bhatnagar, MD, MPH; Clinical Adjunct Professor, Department of Psychiatry; Medical Director and Addiction Psychiatrist, UnityPoint Health-Meriter NewStart
Miranda J. Bice, MD; Clinical Assistant Professor, Department of Orthopedics and Rehabilitation
Donna G. Blankenbaker, MD; Professor, Department of Radiology
Timothy W. Casias, MD; Assistant Professor, Department of Anesthesiology; Medical Director of Pediatric Chronic Pain
June L. Dahl, PhD; Professor Emerita of Neuroscience
Steven J. Garlow, MD, PhD; Professor, Department of Psychiatry
Aaron M. Gilson, MS, MSSW, PhD; Health Policy Research Scientist/Senior Scientist, Sonderegger Research Center, University of Wisconsin-Madison School of Pharmacy
Paul R. Hutson, PharmD, BCOP;* Professor, School of Pharmacy
Cheryl J. Kaltenberg;* Consultant
Elizabeth Lake, MD; Clinical Assistant Professor, Department of Neurology
James W. Leonard, DO, PT;* Associate Professor, Chair Division of Rehabilitation Medicine, Department of Orthopedics and Rehabilitation
Sarah E. McAchran, MD, FACS; Associate Professor, Departments of Urology and Obstetrics & Gynecology
Thomas S. McDowell, MD, PhD; Associate Professor, Department of Anesthesiology
Shilagh A. Mirgain, PhD; Senior Psychologist, Clinical Adjunct Assistant Professor, Department of Orthopedics and Rehabilitation
Tracy Mrochek, MPA, RN; Continuing Education Program Coordinator, Continuing Education in Nursing, University of Wisconsin-Madison School of Nursing; University of Wisconsin–Madison ICEP
Peggy S. Riley, MN, MPH, RN;* Pediatric Pain CNS, American Family Children’s Hospital; Adjunct Faculty, UW School of Nursing
Adam Rindfleisch, MD, MPhil; Associate Professor, Department of Family Medicine and Community Health; Medical Director, UW Integrative Medicine Program
Nathan J. Rudin, MD, MA;* Professor, Department of Orthopedics and Rehabilitation
Susanne Seeger, MD; Associate Professor and Vice Chair; Director, Headache Program, Department of Neurology
Nalini Sehgal, MD;* Professor, Department of Orthopedics and Rehabilitation; Fellowship Director, Pain Medicine; Vice Chair & Director Clinical Services, Rehabilitation Medicine
Shawna K. Wheeler, PA-C; Department of Neurology
Aleksandra E. Zgierska, MD, PhD;* Assistant Professor, Family Medicine, Addiction Medicine, Department of Family Medicine & Community Health; Board of Directors member, Wisconsin Society of Addiction Medicine, American Society of Addiction Medicine
POLICY ON DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Disclosure will be made before the beginning of the activity.
| Name of Individual | Individual's Role in Activity | Name of Commercial Interest & Nature of Relationship | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
| Alaa Abd-Elsayed, MD, MPH | Planner & Presenter, Content Developer | Consultant and Research Agreements with Medtronic and GE; Halyard, Sollis, Stimwave (Consultant) | No |
| Jacquelyn Adams, MD | Presenter | No relevant financial relationships to disclose | No |
| Christi Albert, PharmD BCPS | Presenter | No relevant financial relationships to disclose | No |
| Sreevalli Atluru, MD | Presenter | No relevant financial relationships to disclose | No |
| Miroslav "Misha" Backonja, MD | Planner & Presenter, Content Developer | Lexicon Pharmaceuticals, WEX Pharmaceuticals (Consultant) | NO |
| Terese Bailey | Planner | No relevant financial relationships to disclose | No |
| Ritu Bhatnagar, MD, MPH | Presenter | No relevant financial relationships to disclose | Yes |
| Miranda Bice, MD | Presenter | No relevant financial relationships to disclose | No |
| Donna Blankenbaker, MD | Presenter | No relevant financial relationships to disclose | No |
| Timothy Casias, MD | Presenter | No relevant financial relationships to disclose | Yes |
| Michael Clark, MD, MPH, MBA | Presenter | No relevant financial relationships to disclose | Yes |
| Edward Covington, MD | Presenter | Heron, Mallinckrodt Pharmaceutical, Nektar Pharma, Sage Therapeutics (Consultant) | Yes |
| June Dahl, PhD | Presenter | No relevant financial relationships to disclose | No |
| Oscar de Leon-Casasola, MD | Presenter | Silex (Member of Advisory Committee or Review Panel) | Yes |
| Timothy Deer, MD, DABPM, FIPP | Presenter | Abbott, Axonics, Cornerloc, Ethos, Flowonix, Nalu Medical, Saluda, Spinethera, Vertiflex, Vertos Medical (Consultant); Abbott, Flowonix, Nalu Medical, Vertiflex (Member of Advisory Committee or Review Panel); Abbott, Mainstay Medical, Saluda, Vertiflex (PI); Axonics, Bioness, Cornerloc, Nalu Medical, Saluda, Spinethera, Vertiflex, Vertos, Medical (Stockholder or Other Ownership Interest) | No |
| Rob Edwards, PhD, MSPH | Presenter | No relevant financial relationships to disclose | No |
| John Ewing, MD | Presenter | No relevant financial relationships to disclose | No |
| Thomas Faull, DO, DC | Presenter | No relevant financial relationships to disclose | No |
| David Galbis-Reig, MD, DFASAM | Presenter | Abbott, Abbvie, GW Pharmaceuticals, Hospira Inc. (Stockholder or Other Ownership Interest Holder) | No |
| Steven Garlow, MD, PhD | Presenter | Janssen (Consultant) | No |
| Aaron Gilson, MS, MSSW, PhD | Presenter | No relevant financial relationships to disclose | No |
| Paul Hutson, PharmD, BCOP | Planner & Presenter, Content Developer | Projections Research, Inc. (Consultant) | Yes |
| Cheryl Kaltenberg | Planner | No relevant financial relationships to disclose | No |
| Cara King, DO, MS | Presenter | No relevant financial relationships to disclose | No |
| Elizabeth Lake, MD | Presenter | No relevant financial relationships to disclose | No |
| Michael Larson, PhD | Presenter | Ameritox (PI) | No |
| James Leonard, DO, PT | Planner,Content Developer, Presenter, Educational Reviewer | No relevant financial relationships to disclose | No |
| Sarah McAchran, MD, FACS | Presenter | Pfizer (Stockholder or Other Ownership Interest Holder) | No |
| Thomas McDowell, MD, PhD | Presenter | No relevant financial relationships to disclose | Yes |
| Shilagh Mirgain, PhD | Presenter | No relevant financial relationships to disclose | No |
| Tracy Mrochek, MPA, RN | Planner | No relevant financial relationships to disclose | No |
| Peggy Riley, MN, MPH, RN | Planner & Presenter, Content Developer | No relevant financial relationships to disclose | No |
| Adam Rindfleisch, MD, MPhil | Presenter | No relevant financial relationships to disclose | No |
| Nathan Rudin, MD, MA | Planner, Presenter, Content Developer | No relevant financial relationships to disclose | Yes |
| Susanne Seeger, MD | Presenter | No relevant financial relationships to disclose | No |
| Nalini Sehgal, MD | Planner & Presenter, Content Developer | No relevant financial relationships to disclose | No |
| Marcia Slattery, MD | Content Reviewer | No relevant financial relationships to disclose | No |
| Shawna Wheeler, PA-C | Presenter | No relevant financial relationships to disclose | No |
| Tony Yaksh, PhD | Presenter | Kalyra Pharmaceuticals, Teva Pharmaceuticals (Consultant); Aurimmed Pharma, Calcimedica, Inc., Coda Biotherapeutics, Kalara Pharmaceuticals, Sintetica, Vitagen (Independent Contractor/Researcher); Advanced Targeting, Alyrxx Inc. Ark Animal Health, Asana, Concentric, Epigen, Flowonix, Ipsen, Medtronic, Inc., Sanford Burnham Consortium, Sorrento Therapeutics Inc., Switch Biotherapeutics (PI) | No |
| Annette Zaharoff, MD | Presenter | No relevant financial relationships to disclose | No |
| Aleksandra Zgierska, MD, PhD | Planner, Content Developer, Educational Reviewer | No relevant financial relationships to disclose | No |
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
A maximum of 37.5 hours of knowledge-based CE credit can be earned by successfully completing this live activity. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance and completion of the program assessment and evaluation, will be provided to NABP within 60 days after the activity completion.
Universal Activity Number (UAN) JA0000358-0000-19-069-L01-P 36.75 hours/3.675 CEUs
Universal Activity Number (UAN) JA0000358-0000-19-070-L03-P 0.75 hours/.075 CEUs
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 37.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC) & Iowa Board of Nursing
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 37.5 ANCC contact hours (15 of which are eligible for pharmacotherapeutic contact hours and 37.5 Iowa contact hours.
The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350. A copy of the evaluation(s) may be sent to the Iowa Board of Nursing, 400 SW 8th St., Suite B, Des Moines, IA 50309.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for 3.75 continuing education units (CEUs) or 37.5 hours.
American Academy of Family Medicine
This Live activity, Comprehensive Review of Pain Management, with a beginning date of 08/05/2019, has been reviewed and is acceptable for up to 37.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Addiction Medicine
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Continuous Certification Program (TraCC) can apply for a maximum of 12.75 AMA PRA Category 1 CreditsTM for completing the Comprehensive Review of Pain Management.
Wisconsin Medical Examining Board Opioid CME
This course has been approved by the Wisconsin Medical Examining Board as meeting the requirements for a continuing education course on the responsible opioid prescribing guidelines per Med 13.03(3) of the Wisconsin Administrative Code.
Course title: Comprehensive Review of Pain Management: Day 4
The following instructors have been approved for your course: Multiple
Number of Credits Approved: 7.25
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
Available Credit
- 37.50 ACPE Contact Hours - Pharmacist
- 37.50 AMA PRA Category 1 Credit™
- 37.50 ANCC Contact Hours
- 37.50 Iowa Board of Nursing Contact Hours
- 37.50 University of Wisconsin–Madison Continuing Education Hours
Conference Dates and Fees
August 5-9, 2019
$1250 Physicians
$895 Fellows, Residents, Others (PA/NP/RN/RPh/PharmD, etc.)
$575 UW/VA/Meriter Faculty, Residents, and Staff
REGISTRATION DEADLINE: July 31, 2019.
The conference fee includes the cost of tuition, breakfasts, refreshment breaks, lunches, and a nonrefundable processing fee of $50.
Course Materials
Conference materials will be available to registered participants on Thursday, August 1.
Participants may purchase a paper copy of the syllabus for an additional fee of $94.95 (price includes all applicable taxes).
Requests must be received by Monday, July 15, 2019.
If there are any concerns regarding the electronic syllabus, please contact Terese Bailey or Cheryl Kaltenberg prior to the Symposium.
CANCELLATION AND REFUND POLICY
Requests for cancellation must be submitted in writing to help@icep.wisc.edu. Cancellation requests received by July 29, 2019 will allow a full refund except for the $50 nonrefundable processing fee. No refunds will be made for cancellations received after July 29, 2019.
QUESTIONS ABOUT REGISTRATION
Email help@icep.wisc.edu or call 608-262-7226
PROGRAM CHANGES
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
FOR FURTHER INFORMATION
For conference information or details, please contact Terese Bailey at 608.265.2046 or terese.bailey@wisc.edu